Xiangtan Electrochemical Scientific Co.,Ltd

Xiangtan Electrochemical Scientific Co.,Ltd, headquartered in Xiangtan, China, was established in 1958. The company is a key producer and distributor of electrolytic manganese dioxide (EMD) and advanced materials essential for new energy battery technologies. Its comprehensive product range includes C-Zn grade materials, alkaline and lithium manganese batteries, lithium manganese oxide batteries, and lithium manganate. Additionally, it supplies raw materials for magnetic components, manganese tetroxide, and manganese sulfate. Beyond material manufacturing, Xiangtan Electrochemical also operates in environmental services, undertaking urban sewage and industrial wastewater treatment, sludge management, and the research, development, and implementation of utility technologies, alongside providing relevant technical support. The company further diversifies its operations through trading in various commodities such as ferromanganese alloys, electrolytic manganese metal, primary and secondary battery materials, manganese dioxide, manganese tetroxide, catalysts, discharge manganese, manganese carbonate ore, oxidized manganese ore, and fund tray trading. With a significant international presence, its products are exported to approximately 20 countries globally, including major markets like the United States, Japan, the European Union, and countries across Southeast Asia.

Xiangtan Electrochemical Scientific Co.,Ltd trades as 002125.SZ on SHZ. The company is classified in Basic Materials / Chemicals and reports in CNY.

The current profile places the business in Chemicals. This section is intended to summarize the operating segments, products, geographies, and main revenue lines from official filings.

Detailed operating-segment data is not available for this symbol yet.

Use this area for management strategy, capital allocation priorities, target markets, and measurable goals from the latest annual report or investor presentation.

The app now provides the structure, but exact strategic claims should come from official company documents before being treated as a finished investment thesis.

Xiangtan Electrochemical Scientific Co.,Ltd can be compared against peers such as FSPG Hi-Tech Co. Ltd., Guangdong Orient Zirconic Ind Sci & Tech Co.,Ltd, Lier Chemical Co.,LTD., Suzhou Hesheng Special Material Co., Ltd., Nantong Jiangshan Agrochemical & Chemicals Co.,Ltd., Jiangsu SOPO Chemical Co. Ltd..

A complete thesis should compare growth, margins, balance-sheet risk, valuation multiples, and market position against direct competitors.

Current signals to investigate include market capitalization of $11.82B, beta of 0.45, and return on equity of N/A.

This section should be validated with evidence such as durable margins, brand strength, regulation, switching costs, cost advantage, distribution, or technology.

Key risks should include financial leverage, cyclicality, customer concentration, regulatory exposure, currency risk, and execution risk.

002125.SZ currently shows total debt of N/A and beta of 0.45. Missing data should be treated as a research gap, not as low risk.

Production-capacity detail is not available as structured data yet. For industrial, defense, semiconductor, or real-estate companies, this should be reviewed from annual reports and investor presentations.

No structured backlog field is available yet. If the company reports backlog, review the relevant filing section before adding it to the thesis.

Use this section for major contracts, product launches, construction projects, acquisitions, or strategic programs that can materially affect valuation.

No recent SEC-style filings are available for this symbol yet.

Customer concentration is not available as structured data here. Add it from official filings when a company discloses material customers or revenue concentration.

Supplier concentration and critical supply-chain dependencies are not available as structured data here. This should be researched from annual reports and risk disclosures.

Company website: https://www.chinaemd.com

For US-listed stocks, verify the thesis against official filings, earnings call transcripts, and company investor relations materials.